2021 PTCTC Meeting Schedule
Tuesday, April 20, 2021
The Pediatric Transplantation and Cellular Therapy Consortium (PTCTC) Educational Program will include a day focused on pediatric transplantation and cellular therapy on Tuesday of the 2021 ASPHO Conference. The sessions will invigorate and encourage physicians to learn more about a rapidly advancing field. The one-day virtual meeting also allows pediatric hematology/oncology practitioners who do a small amount of transplantation and cellular therapy to attend a meeting in which they wouldn’t normally have access.
For questions or additional information, visit www.theptctc.org or contact This email address is being protected from spambots. You need JavaScript enabled to view it. .
Schedule (times listed are in Central Time/CT)
9:45 –10 am
Welcome and Introduction
Christine N. Duncan, MD, MMSC
10–11 am
Acute Transplant-Related Endothelial Injury Syndromes
Moderator: Kris Mahadeo, MD MPH
The Endothelium as a Target of Transplant Related Injury
Keri L. Schadler, PhD
Treating TMA: Who, When, and For How Long
Sonata Jodele, MD
11 am–12 pm
Infectious Disease Management in the Current Era of Hematopoietic Cell Transplant and Cell Therapies
Moderator: Jeffery J. Auletta, MD
Preventing Infection in the Transplant Recipient: Is An Ounce of Prevention Really Worth a Pound of Cure?
Brian T. Fisher, DO, MSCE
Assessing the Clinical Utility of New Diagnostics in Infection Surveillance and Diagnosis
Alpana Waghmare, MD
Emerging Pathogens and Therapies: Bugs, Drugs and Due Diligence
Monica Ardura, DO, MSC
12–12:15 pm
Break
12:15–1:15 pm
Unique Considerations in the Acute and Chronic Management of Children Transplanted for Non-malignant Disorders
Moderators: James LaBelle, MD and Jennifer Whangbo, MD PhD
Acute Toxicity in Patients with Immune Dysregulation Disorders
Jennifer Whangbo, MD PhD
MPS Disorders: Before, After, and During Transplant
Kristen Page, MD
Surviving Transplant for Sickle Cell Disease
James LaBelle, MD
1:15–2 pm
Oral Abstract Presentations
Moderator: Christine N. Duncan, MD, MMSC
2–3 pm
Multidisciplinary Onco-Transplant Critical Care
Moderator: Matt Zinter, MD
Acute Delirium in ICU and HCT Patients
Chani Traube, MD
ECMO: Who, When, and Why: An Interactive Panel Debate Panel
Panel led by Matt Zinter, MD
3–3:15 pm
Break
3:15–4:15 pm
Acute and Chronic Transplant-Related Failure
Moderator: Sangeeta Hingorani, MD MPH
Acute Kidney Injury after Hematopoietic Cell Transplant – Management and Outcomes
Joseph Angelo, MD
BK Polyoma Virus after Hematopoietic Cell Transplant
Ben Laskin, MD
4:15–5:15 pm
Social and Environmental Determinants of Morbidity
Moderator: Christopher E. Dandoy, MD, MSC
The Impact of Poverty on Survival and Outcome
Kira Bona, MD MPH
Depression and Anxiety in Patients and Families and Impact on Morbidity
Ahna Pai, PhD
Continuing Medical Education Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society of Pediatric Hematology/Oncology (ASPHO) and the Pediatric Transplantation and Cellular Therapy Consortium (PTCTC). The American Society of Pediatric Hematology/Oncology is accredited by the ACCME to provide continuing medical education for physicians.
The American Society of Pediatric Hematology/Oncology designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, ASPHO requires all planners, faculty (presenters and moderators), reviewers, teachers, authors, and any others involved in the development of CME content to disclose all financial relationships they have with ineligible companies in the last 24 months. Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. ASPHO also requires disclosure of the intent to discuss unlabeled or investigational use(s) of a commercial product or investigational use of a product not yet approved for this purpose. The ASPHO Accreditation Subcommittee reviews all financial relationships as submitted in the disclosure form by planners and presenters and resolves such conflicts to ensure the content of the activity is aligned with the interests of the public.
Disclaimer
The materials presented in this activity represent the opinions of the speakers and not necessarily the views of ASPHO or PTCTC.
PTCTC Conference Planning Committee
Jeffery J. Auletta, MD
Nationwide Children's Hospital
Columbus, OH
Mitchell S. Cairo, MD
New York Medical College
Valhalla, NY
Christopher E. Dandoy, MD, MSC
Cincinnati Children's Hospital
Cincinnati, OH
Christine Duncan, MD MMSC
Dana Farber Cancer Institute/Boston Children's Hospital
Boston, MA
Sangeeta Hingorani, MD MPH
Seattle Children's Hospital
Seattle, WA
Leslie S. Kean, MD PhD
Boston Children's Hospital
Boston, MA
James LaBelle, MD
University of Chicago
Chicago, IL
Kris Mahadeo, MD MPH
The University of Texas MD Anderson Cancer Center
Houston, TX
Jennifer Whangbo, MD PhD
Dana-Farber Cancer Institute/Boston Children’s Hospital
Boston, MA
Matt Zinter, MD
University of California, San Francisco
San Francisco, CA
PTCTC Conference Planning Committee Disclosures
Relevant financial relationships to disclose: Christine Duncan - Magenta Therapeutics, bluebird bio: Consultant, honorarium; Omeros: Advisory board, honorarium; Leslie Kean - Kymab, Fortyseven: Consultant, Consulting Fees; Bristol-Myers Squibb, Regeneron: Investigator Sponsored Research, Research Funding; HiFlBio: Scientific Advisory Board Member, SAB renumeration
ASPHO Accreditation Subcommittee Disclosures
No relevant relationships: Tanya Renae Brown, Cathleen Cook, Jennifer Domm, Chandrika Gowda, Mary-Jane S. Hogan, Jeffrey Hord, Karen Lewing, Kate Mazur, Mukta Sharma
ASPHO and PTCTC Staff Disclosures
No relevant relationships: Hati Kobusingye, Cassie McGarigle, Ryan Wilkinson
PTCTC Faculty
Joseph Angelo, MD
Texas Children's Hospital
Houston, TX
Monica Ardura, DO, MSC
Nationwide Children's Hospital
Columbus, OH
Jeffery J. Auletta, MD
Nationwide Children's Hospital
Columbus, OH
Kira Bona, MD, MPH
Dana-Farber Cancer Institute/Boston Children’s Hospital
Boston, MA
Christopher E. Dandoy, MD, MSC
Cincinnati Children's Hospital
Cincinnati, OH
Christine N. Duncan, MD MMSC
Dana-Farber Cancer Institute/Boston Children’s Hospital
Boston, MA
Brian T. Fisher, DO, MSCE
Children's Hospital of Philadelphia
Philadelphia, PA
Sangeeta Hingorani, MD MPH
Seattle Children's Hospital
Seattle, WA
Sonata Jodele, MD
Cincinnati Children's Hospital
Cincinnati, OH
James LaBelle, MD
University of Chicago
Chicago, IL
Benjamin Laskin, MD
Children's Hospital of Philadelphia
Philadelphia, PA
Kris Mahadeo, MD MPH
The University of Texas MD Anderson Cancer Center
Houston, TX
Ahna Pai, PhD
Cincinnati Children's Hospital
Cincinnati, OH
Kristen Page, MD
Duke University
Durham, NC
Keri L. Schadler, PhD
The University of Texas MD Anderson Cancer Center
Houston, TX
Chani Traube, MD
Memorial Sloan Kettering Cancer Center
New York, NY
Alpana Waghmare, MD
Seattle Children's Hospital
Seattle, WA
Jennifer Whangbo
Dana-Farber Cancer Institute/Boston Children’s Hospital
Boston, MA
Matt Zinter, MD
University of California, San Francisco
San Francisco, CA